Articles |
From the Departments of Internal Medicine (P.W., J.W.H.) and Molecular Biology and Pharmacology (J.W.H.), Washington University School of Medicine, St Louis, Mo.
Correspondence to Dr Jay W. Heinecke, Division of Atherosclerosis, Nutrition and Lipid Research, Box 8046, 660 South Euclid Ave, St. Louis, MO 63110. E-mail heinecke{at}im.wustl.edu
Abstract Oxidized LDL is implicated in the pathogenesis of
atherosclerosis. A widely studied model for oxidation
of the lipid in LDL involves Cu2+. Recent studies suggest
that Cu2+ may be reduced to Cu1+ by
-tocopherol to initiate LDL lipid peroxidation. LDL
demonstrates binding sites for Cu2+, but the nature of
these binding sites, as well their role in promoting Cu2+
reduction and lipid peroxidation, has not been established. In the
current studies, we used diethylpyrocarbonate (DEPC) to modify the
histidine residues of apolipoprotein B100, the major protein in LDL.
First, we demonstrated that histidine residues were preferentially
modified by DEPC under our experimental conditions. Then we monitored
the kinetics of Cu2+-promoted oxidation of LDL and
DEPC-modified LDL. In both cases, the progress curve of lipid
peroxidation exhibited a lag phase and a propagation phase. However,
when LDL was modified with DEPC, the length of the lag phase was
prolonged whereas the rate of lipid peroxidation during the propagation
phase was lower. Studies with LDL oxidized by 2,2'-azobis
(2-amidinopropane) hydrochloride and phosphatidylcholine liposomes
oxidized with hydroxyl radical established that DEPC was not acting
simply as a nonspecific inhibitor of lipid peroxidation.
DEPC treatment of LDL almost completely inhibited its ability to bind
Cu2+. These observations suggest that peroxidation of the
lipids in LDL can proceed with normal kinetics only when
Cu2+ binds preferentially to sites on apolipoprotein B100
that contain histidine residues. We also compared the kinetics of
Cu2+ reduction in the absence and presence of DEPC. There
was no effect of DEPC modification on either the rate or extent of
Cu2+ reduction by LDL. Therefore LDL is likely to contain a
second class of binding sites for Cu2+ that does not
involve histidine residues. Thus, LDL appears to contain at least two
classes of Cu2+-binding sites: histidine containing sites,
which are responsible in part for promoting lipid peroxidation during
the propagation phase, and sites at which Cu2+ is reduced
without binding to histidine.
Key Words: LDL oxidation atherosclerosis lipid peroxidation metal binding vitamin E
This article has been cited by other articles:
![]() |
A. Roland, R. A. Patterson, and D. S. Leake Measurement of Copper-Binding Sites on Low Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 594 - 602. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |